BioAtla, Inc.
BCAB
$4.54
$0.020.44%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 14.57% | 20.91% | 43.08% | 48.11% | 43.48% |
| Total Depreciation and Amortization | -59.68% | -45.35% | -31.89% | -25.68% | -24.24% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -25.24% | -38.60% | -56.96% | -54.39% | -40.10% |
| Change in Net Operating Assets | 144.33% | 107.68% | 111.29% | 69.04% | -339.29% |
| Cash from Operations | 32.99% | 32.92% | 51.23% | 48.84% | 30.84% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -98.95% | 2,281.68% | 2,199.75% | 2,744.35% | 2,744.35% |
| Repurchase of Common Stock | -13.04% | 47.37% | 58.97% | 60.26% | 82.24% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -34.01% | 2,700.00% | 2,957.93% | 4,971.67% | 12,251.95% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 32.83% | 43.14% | 59.40% | 56.93% | 40.00% |